These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26008846)

  • 1. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
    Eriksson P; Aine M; Veerla S; Liedberg F; Sjödahl G; Höglund M
    BMC Med Genomics; 2015 May; 8():25. PubMed ID: 26008846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of the luminal class of urothelial tumors.
    Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
    J Pathol; 2019 Nov; 249(3):308-318. PubMed ID: 31232464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a molecular pathologic classification of urothelial carcinoma.
    Sjödahl G; Lövgren K; Lauss M; Patschan O; Gudjonsson S; Chebil G; Aine M; Eriksson P; Månsson W; Lindgren D; Fernö M; Liedberg F; Höglund M
    Am J Pathol; 2013 Sep; 183(3):681-91. PubMed ID: 23827819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular taxonomy for urothelial carcinoma.
    Sjödahl G; Lauss M; Lövgren K; Chebil G; Gudjonsson S; Veerla S; Patschan O; Aine M; Fernö M; Ringnér M; Månsson W; Liedberg F; Lindgren D; Höglund M
    Clin Cancer Res; 2012 Jun; 18(12):3377-86. PubMed ID: 22553347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
    Warrick JI; Walter V; Yamashita H; Chung E; Shuman L; Amponsa VO; Zheng Z; Chan W; Whitcomb TL; Yue F; Iyyanki T; Kawasawa YI; Kaag M; Guo W; Raman JD; Park JS; DeGraff DJ
    Sci Rep; 2016 Dec; 6():38531. PubMed ID: 27924948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.
    Eriksson P; Sjödahl G; Chebil G; Liedberg F; Höglund M
    Oncotarget; 2017 Jul; 8(30):48905-48914. PubMed ID: 28388586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort.
    Marzouka NA; Eriksson P; Rovira C; Liedberg F; Sjödahl G; Höglund M
    Sci Rep; 2018 Feb; 8(1):3737. PubMed ID: 29487377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
    Sjödahl G; Eriksson P; Liedberg F; Höglund M
    J Pathol; 2017 May; 242(1):113-125. PubMed ID: 28195647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
    Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
    Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
    Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
    Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.
    de Matos Simoes R; Dalleau S; Williamson KE; Emmert-Streib F
    BMC Syst Biol; 2015 May; 9():21. PubMed ID: 25971253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.
    Iyyanki T; Zhang B; Wang Q; Hou Y; Jin Q; Xu J; Yang H; Liu T; Wang X; Song F; Luan Y; Yamashita H; Chien R; Lyu H; Zhang L; Wang L; Warrick J; Raman JD; Meeks JJ; DeGraff DJ; Yue F
    Genome Biol; 2021 Apr; 22(1):105. PubMed ID: 33858483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants.
    Al-Ahmadie H; Iyer G
    Surg Pathol Clin; 2018 Dec; 11(4):713-723. PubMed ID: 30447837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
    DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
    PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
    Shelekhova KV; Krykow KA; Mescherjakov IA; Mitin NP
    Int J Surg Pathol; 2019 Aug; 27(5):483-491. PubMed ID: 30854907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.
    Heubach J; Monsior J; Deenen R; Niegisch G; Szarvas T; Niedworok C; Schulz WA; Hoffmann MJ
    Mol Cancer; 2015 May; 14():108. PubMed ID: 25994132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium.
    Fishwick C; Higgins J; Percival-Alwyn L; Hustler A; Pearson J; Bastkowski S; Moxon S; Swarbreck D; Greenman CD; Southgate J
    Cell Death Differ; 2017 May; 24(5):809-818. PubMed ID: 28282036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
    Sjödahl G
    Methods Mol Biol; 2018; 1655():53-64. PubMed ID: 28889377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.